A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib Malate
Roger Lecomte
PloS one, 2017
View PDFchevron_right
Non-Targeted Metabolomics Analysis of the Effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Muscle, Liver and Serum Metabolism In Vivo
Traci Parry
Metabolites, 2017
View PDFchevron_right
Sunitinib-induced cardiac hypertrophy and the endothelin axis
Pierre-Louis Tharaux
Theranostics, 2021
View PDFchevron_right
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Flavia Cassiola
Lancet, 2007
View PDFchevron_right
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Commentary
Nesreen Ismail
Lancet, 2007
View PDFchevron_right
Sunitinib-Induced Cardiotoxicity Is Mediated by Off-Target Inhibition of AMP-Activated Protein Kinase
Jean-bernard Durand
Clinical and Translational Science, 2009
View PDFchevron_right
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents
Sandra Donnini
Cardio-Oncology, 2016
View PDFchevron_right
Mechanisms of Cardiovascular Damage Induced by Traditional Chemotherapy
Giulio Agnetti
Cardiovascular Complications in Cancer Therapy, 2018
View PDFchevron_right
Differences in Effects on Myocardium and Mitochondria by Angiogenic Inhibitors Suggest Separate Mechanisms of Cardiotoxicity
Emile Chen
Toxicologic Pathology, 2010
View PDFchevron_right
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection
Christian Cadeddu
Heart Failure Reviews, 2015
View PDFchevron_right
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes
Brian Necela
Clinical and translational medicine, 2017
View PDFchevron_right
Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin
Theo Wallimann
Comptes Rendus Biologies, 2006
View PDFchevron_right
Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor Inhibition
Traci Parry
Journal of the American Heart Association, 2017
View PDFchevron_right
The utility of serum biomarkers to detect myocardial alterations induced by Imatinib in rats
Alan Knapton
Pharmacology Research & Perspectives, 2014
View PDFchevron_right
Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non-targeted metabolomics analysis
Traci Parry
British journal of pharmacology, 2017
View PDFchevron_right
560 POSTER Inhibition of erbB 1/2 by small molecule tyrosine kinase inhibitors, but not trastuzumab, affects metabolic pathways: implications to cardiac toxicity
Sarah Bacus
Ejc Supplements, 2006
View PDFchevron_right
Cardiac metabolism as a driver and therapeutic target of myocardial infarction
Tuuli Kaambre
Journal of Cellular and Molecular Medicine, 2020
View PDFchevron_right
Metabolic Intersection of Cancer and Cardiovascular Diseases: Opportunities for Cancer Therapy
Kiet Nguyen
The Heterogeneity of Cancer Metabolism, 2021
View PDFchevron_right
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart
Carlo Gabriele Tocchetti
Cardiovascular Research
View PDFchevron_right
The Anti-Cancer Multikinase Inhibitor Sorafenib Impairs Cardiac Contractility by Reducing Phospholamban Phosphorylation and Sarcoplasmic Calcium Transients
Heinrich Mächler
Scientific Reports, 2018
View PDFchevron_right
Update on cardiotoxicity of anti-cancer treatments
Gian Rosa
European Journal of Clinical Investigation, 2016
View PDFchevron_right
Cardiac Molecular Remodeling by Anticancer Drugs: Doxorubicin Affects More Metabolism While Mitoxantrone Impacts More Autophagy in Adult CD-1 Male Mice
Margarida Duarte Araújo
Biomolecules
View PDFchevron_right
Systems pharmacological analysis of mitochondrial cardiotoxicity induced by selected tyrosine kinase inhibitors
Sihem Ait-Oudhia
Journal of Pharmacokinetics and Pharmacodynamics, 2018
View PDFchevron_right
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
Marco Bruno Morelli
Frontiers in Cardiovascular Medicine
View PDFchevron_right
Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs
Giulio Agnetti
Journal of cardiac failure, 2016
View PDFchevron_right
A Multifaceted Evaluation of Imatinib-induced Cardiotoxicity in the Rat
Thuc Lu
Toxicologic Pathology, 2011
View PDFchevron_right
Cardiac MRI Myocardial Functional and Tissue Characterization Detects Early Cardiac Dysfunction in a Mouse Model of Chemotherapy‐Induced Cardiotoxicity
Nivedita Naresh
NMR in Biomedicine, 2020
View PDFchevron_right
Cardiotoxicity of cancer chemotherapy: identification, prevention and treatment
Diwakar Jain
Annals of Translational Medicine
View PDFchevron_right
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
Jean-bernard Durand
Nature Medicine, 2006
View PDFchevron_right